Lipolytic Effects of Cyclic Adenosine-3',5'-monophosphate and Its Butyryl Derivatives in Vitro, and Their Inhibition by Alpha- and Beta-adrenolytics
Overview
Biology
Physiology
Authors
Affiliations
Studies on the site of action of tolbutamide in the lipolytic system.
Rosak C, Bartelt K, Beyer J, SCHOFFLING K Diabetologia. 1972; 8(3):185-8.
PMID: 4403055 DOI: 10.1007/BF01212259.
The second messenger concept and lipid metabolism.
Butcher R Naunyn Schmiedebergs Arch Pharmakol. 1971; 269(2):358-72.
PMID: 4397726 DOI: 10.1007/BF01003050.
Hormonal control of carbohydrate and lipid metabolism and drug induced alterations.
SENFT G Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968; 259(2):117-48.
PMID: 4385648 DOI: 10.1007/BF00537742.
Effects of antilipolytic drugs on cyclic 3',5'-AMP dependent protein kinase.
Dinnendahl V, Peters H, Schonhofer P Naunyn Schmiedebergs Arch Pharmacol. 1973; 278(3):293-300.
PMID: 4354639 DOI: 10.1007/BF00500290.
The role of cyclic adenosine-3',5'-monophosphate (AMP) in gastrointestinal secretion.
Scratcherd T, Case R Gut. 1969; 10(11):957-61.
PMID: 4311612 PMC: 1553053. DOI: 10.1136/gut.10.11.957.